LeukoDx, Inc. — Form D
LeukoDx, Inc. of San Jose, CA, a company, filed a Form D exempt-offering notice with the SEC on 2010-08-02. The offering totals $1.3M, of which $250K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2010-08-02
- Form: D
- Accession: 0001470820-10-000004
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $1.3M
- Amount sold: $250K
- Remaining: $1.1M
- Minimum investment: $100K
- Investors: 1
- Date of first sale: 2010-07-24
- Security types: equity, debt
- Revenue range: Decline to Disclose
- SEC file number: 021-145790
Issuer
- Name: LeukoDx, Inc.
- CIK: 0001470820
- Entity type: Corporation
- Jurisdiction: MARYLAND
- Incorporated: 2010
- Address: 2385 Bering Drive, San Jose, CA, 95131
- Phone: 6172285729
Officers, directors & promoters (14)
| Name | Role | Location |
|---|
| Bruce Davis | Director | Towson, MD |
| Walter Drimer | Director | Towson, MD |
| Harvey Kasdan | Director | Towson, MD |
| Julien Meissonnier | Director | Towson, MD |
| Marvin Slepian | Director | Towson, MD |
| Walter Drimer | Executive Officer | Towson, MD |
| Julien Meissonnier | Executive Officer | Towson, MD |
| Mark Chess | Director | Grand Rapids, MI |
| Nir Nimrodi | Director | Rehovot, L3 |
| Michael Reynier | Director | Boulder, CO |
| Bruce Sholk | Director | San Jose, CA |
| Barry Zubrow | Director | San Jose, CA |
| Charles Piazza | Director | San Jose, CA |
| Steve Hurvitz | Director | San Jose, CA |
Other filings by this issuer (4)
More